Therefore, given the utilization of etoposidase and other Topo IIα inhibitors in current medulloblastoma chemotherapies, inhibition of Gmnn in this context might have the potential to enhance efficacy and/or re-sensitize resistant cells. Here, GMNN is linked to medulloblastoma.